Apr 05, 2017 12:00 pm UTC| Business
RESEARCH TRIANGLE PARK, N.C., April 05, 2017 -- JAGGAER, producers of the world's most comprehensive Source to Pay (S2P) solutions suite, today announces Gazelle (Release 17.1), reflecting upgrades to its entire product...
H/Cell Energy Appoints Two Board Members
Apr 05, 2017 12:00 pm UTC| Business
FLEMINGTON, N.J., April 05, 2017 -- H/Cell Energy Corporation (OTCQB:HCCC), a company developing clean energy solutions featuring hydrogen energy systems, has announced that effective April 3, 2017, it has appointed...
Neothetics Announces Issuance by USPTO of Eighth Patent Directed to LIPO-202 Lead Clinical Asset
Apr 05, 2017 12:00 pm UTC| Business
SAN DIEGO, April 05, 2017 -- Neothetics, Inc. (NASDAQ:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market today announced the issuance of U.S. Patent Number...
Quadrant 4 System Corporation Launches New Website for Health Division
Apr 05, 2017 12:00 pm UTC| Business
SCHAUMBURG, Ill., April 05, 2017 -- Quadrant 4 System Corporation (OTC:QFOR) announced today the launch of a newly revamped website for Quadrant 4 Health at www.quadrant4health.com. The redesigned website offers...
EASL Selects Albireo’s A4250 Data for Late Breaker Presentation
Apr 05, 2017 12:00 pm UTC| Business
BOSTON, April 05, 2017 -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced that clinical data from the ongoing Phase 2...
Apr 05, 2017 11:45 am UTC| Business
LAS VEGAS, April 05, 2017 -- Everi Holdings Inc. (NYSE:EVRI) (“Everi” or the “Company”) will demonstrate the industry’s only comprehensive portfolio of gaming entertainment and payments solutions that help casino...
Abeona Announces Rare Disease Gene Therapy Symposium with the New York Academy of Sciences
Apr 05, 2017 11:43 am UTC| Business
Company CEO to Co-Chair Symposium being held on April 11th in NYC NEW YORK and CLEVELAND, April 05, 2017 -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on...